Description

n-[N5-[Imino[(Trifluoroacetyl)Amino]Methyl]-N2-[1-[S-(2-Methoxy-2-Oxoethyl)-n-(Trifluoroacetyl)-L-Cys-]L-Pro-]-L-Orn-]Gly-Ome is a sophisticated, high-purity synthetic peptide derivative designed for advanced research and development applications. This compound is valued for its role as a key intermediate or building block in the synthesis of complex bioactive molecules, particularly in pharmaceutical discovery. It is primarily utilized by research institutions and pharmaceutical companies engaged in the development of novel therapeutic agents, including enzyme inhibitors and targeted drug candidates.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel peptide-based drug candidates and active pharmaceutical ingredients (APIs).
• Biochemical Research: Used in proteomics and enzymology studies as a substrate or inhibitor analog to investigate enzyme mechanisms and protein interactions.
• Medicinal Chemistry: Employed in structure-activity relationship (SAR) studies to optimize the potency and selectivity of therapeutic compounds.
• Peptide Synthesis: Acts as a protected or modified amino acid derivative in solid-phase and solution-phase peptide synthesis for creating custom sequences.
• Protease Inhibitor Development: Provides a structural scaffold for designing and testing new inhibitors targeting specific proteolytic enzymes.

Basic Information

Product Name	n-[N5-[Imino[(Trifluoroacetyl)Amino]Methyl]-N2-[1-[S-(2-Methoxy-2-Oxoethyl)-n-(Trifluoroacetyl)-L-Cys-]L-Pro-]-L-Orn-]Gly-Ome
CAS No.	72060-17-4
Molecular Formula	C24H32F6N6O9S
Molecular Weight	694.60 g/mol
Synonyms	Glycine, N-[N5-[imino[(trifluoroacetyl)amino]methyl]-N2-[1-[S-(2-methoxy-2-oxoethyl)-N-(trifluoroacetyl)-L-cysteinyl]-L-prolyl]-L-ornithyl]-, methyl ester; Methyl N-[(2S)-5-[[(Z)-[amino(trifluoroacetyl)amino]methylene]amino]-2-[[(2S)-1-[(2R)-2-[(2-methoxy-2-oxoethyl)thio]-2-[(2,2,2-trifluoroacetyl)amino]ethyl]pyrrolidine-2-carbonyl]amino]pentyl]glycinate; (S)-Methyl 2-(5-((Z)-(amino(trifluoroacetamido)methylene)amino)-2-((S)-1-((R)-2-((2-methoxy-2-oxoethyl)thio)-2-(2,2,2-trifluoroacetamido)ethyl)pyrrolidine-2-carboxamido)pentylamino)acetate; TFA-protected Cysteine-Proline-Ornithine-Glycine derivative; Peptide building block 72060-17-4.
EINECS	Contact for details

Quality Control

Our n-[N5-[Imino[(Trifluoroacetyl)Amino]Methyl]-N2-[1-[S-(2-Methoxy-2-Oxoethyl)-n-(Trifluoroacetyl)-L-Cys-]L-Pro-]-L-Orn-]Gly-Ome is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and tests for residual solvents and moisture content. Certificates of Analysis (COA) detailing all specifications are provided to ensure traceability and compliance with your research or cGMP guidelines.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled under anhydrous conditions to maintain stability and purity. For long-term storage, consider desiccation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (MS)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 2.0%
Residual Solvents (GC)	Meets ICH guidelines
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.